Short answer
KORU Medical Systems, Inc. (KRMD) filed an 8-K current report with the SEC on March 16, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). CEO Linda Tharby retiring June 30, 2026; replaced by Kalbermatten (current exec) as President March 15, CEO July 1: planned succession, not abrupt departure.
KORU Medical Systems, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CEO Linda Tharby retiring June 30, 2026; replaced by Kalbermatten (current exec) as President March 15, CEO July 1: planned succession, not abrupt departure
- Kalbermatten base salary steps up from $450K to $525K on July 1, 2026; 2026 LTI target $1,250,000 plus one-time $1,250,000 Promotion PSU tied to revenue growth (75%) and market cap (25%)
- Tharby advisory period through Dec 31, 2026 at 50% of prior base salary; 220,000 PSUs vested on 2025 performance, 200,000 PSUs previously cancelled for missing thresholds: signals mixed recent performance
- Tharby irrevocably waived Change of Control vesting acceleration on trailing revenue run-rate provision: reduces potential M&A payout overhang for acquirers
- Kalbermatten severance: 12-month salary continuation + 100% bonus target if terminated without Cause; full equity acceleration on Change of Control, standard but noteworthy given $2.5M+ in new equity grants
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other KORU Medical Systems, Inc. 8-K filings
Get the next KRMD 8-K as it lands
Follow KRMD for push alerts, or ask the research agent what this filing means.